Frontlight ResearchEarly access
Trial site
Columbus
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 11 trial
- Phase 31 trial
- Status
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- TG Therapeutics, Inc.3 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Myasthenia gravis1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026